Human CD38: a (r)evolutionary story of enzymes and receptors
about
RanBPM associates with CD39 and modulates ecto-nucleotidase activityDaratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myelomaMonoclonal antibodies targeting CD38 in hematological malignancies and beyondPotential role of daratumumab in the treatment of multiple myelomaDevelopment of Novel Immunotherapies for Multiple MyelomaCD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemiaFunctional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaEvolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathologyHIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral disseminationIdentification and functional characterization of the hepatic stellate cell CD38 cell surface moleculeProliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood.Analysis of Real-World Data on Overall Survival in Multiple Myeloma Patients With ≥3 Prior Lines of Therapy Including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or Double Refractory to a PI and an IMiD.CD38 as a therapeutic target.CD38 facilitates recovery from traumatic brain injuryImmunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection.Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data.New additions to antibody panels in the characterisation of chronic lymphoproliferative disordersT cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite ControllersSystems biology of vaccination for seasonal influenza in humans.Modeling Bone Marrow Progenitor Cell Differentiation and Susceptibility to HIV-1 InfectionDaratumumab monotherapy compared with historical control data in heavily pretreated and highly refractory patients with multiple myeloma: An adjusted treatment comparison.Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma.The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes.The human placenta is a hematopoietic organ during the embryonic and fetal periods of development.c-Cbl tyrosine kinase-binding domain mutant G306E abolishes the interaction of c-Cbl with CD38 and fails to promote retinoic acid-induced cell differentiation and G0 arrestEctonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Monoclonal antibody-based immunotherapy for multiple myeloma.Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.Elotuzumab and daratumumab: emerging new monoclonal antibodies for multiple myeloma.Monoclonal antibodies currently in Phase II and III trials for multiple myeloma.c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells.Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease.The prospects and promise of chimeric antigen receptor immunotherapy in multiple myeloma.Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting.Molecular docking and CoMFA studies of thiazoloquin(az)olin(on)es as CD38 inhibitors: determination of inhibitory mechanism, pharmacophore interactions, and design of new inhibitors.Sphingolipid microdomains mediate CD38 internalization: topography of the endocytosis.Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
P2860
Q24304417-23C85BAB-C59D-4101-99E2-E1DD39C4DDB2Q26745919-3CB7DAF0-C8FF-49CC-84C7-284FE28E90E8Q26766718-5CFA4594-7400-4E17-83F8-78D70EBAD49EQ26824157-405D7C82-8778-46AA-960B-5C72941FAB4EQ28066890-DB127ECF-6B5A-427E-B83D-951CFD8B5915Q28072550-8D99C5F9-5F6F-42E6-8832-D1FAC952C619Q28282822-D30F4A26-37CE-4C74-90CD-AEC28ACED4B3Q28287124-AB220154-FD16-4261-B939-4D600D47C9E9Q28474374-9BCBF29D-929A-4544-A51F-3316DF30053DQ28573700-34082697-C31B-43A3-9FD3-D51BC643D8CEQ30484652-54B4D39C-CCC4-4C7A-B8C0-69CC16B7243DQ31119290-F4E0B180-BF7D-4932-9FAA-917A1DFF521EQ33279758-5B622552-099F-4A87-9FEC-CFAFCCF7F6ADQ33829410-EE3F8E84-E478-4A69-A380-A91358390F77Q33930475-1837FD9D-3FA1-4E0A-A91F-6EB600D261B5Q34046941-934F3929-0965-4E17-8F91-7B980498C543Q34564844-910CD96C-C0FB-4E22-B613-42E9214E5E56Q35090639-7C9D46CE-B6AA-4DD3-9B81-97BFAFE16D3EQ35118722-655C58CE-85BA-48CC-9BC4-C54C7F028AD0Q35896933-C8C88299-0EFD-4C8D-963F-D230F47E2DD4Q36363958-B3FFAA38-FFF5-4FAD-B77E-E69DD950C8DEQ37076421-94A2AEE9-0D4F-46E2-BD4B-6EBED8C289B4Q37135558-F908401D-D9CB-4165-A43D-389F950DEFC9Q37157635-1C96468D-3489-4A23-A408-94617C8B7C7FQ37377645-2F2214B0-912E-49B5-8B7A-7426D575B931Q37876541-324A2209-118E-4584-AA26-365C9B4CAAEDQ37919717-E0A9A6A2-DD8F-4ADB-8709-3157E77A0AABQ38014834-954A1CF5-3332-4A34-8535-FC802202CA8CQ38050507-A0F4CFC7-1BB2-4B4A-9F90-581E0AC38AECQ38090691-4D3692D7-12B6-4774-8721-7BDCA251E7FAQ38139998-1FCACECC-0EE9-41AC-B98E-37D75B0CAA6DQ38205856-38993F70-4C87-4EB5-A0D9-28A3053E9621Q38359517-8724DD4E-0279-40FB-892C-30B3A8F04F48Q38360962-86193028-E555-4B08-BCB6-46439AD1B43AQ38764944-2215DF8C-6853-48B4-B1A1-F1B68AFF3FD4Q38817467-655F69B6-3C86-4140-B131-D9D6D93BAD77Q39369772-6E1ED579-690B-42A7-98A9-2F3947B2EFB0Q39438950-3661558F-7B37-41D3-B6C6-6CF9752A4074Q40508591-6FC04682-F104-48F7-8D39-76105CD64930Q42857041-6FE6803F-B7DD-4D78-9FFA-D3C72D3CAC7A
P2860
Human CD38: a (r)evolutionary story of enzymes and receptors
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human CD38: a (r)evolutionary story of enzymes and receptors
@ast
Human CD38: a (r)evolutionary story of enzymes and receptors
@en
Human CD38: a (r)evolutionary story of enzymes and receptors
@nl
type
label
Human CD38: a (r)evolutionary story of enzymes and receptors
@ast
Human CD38: a (r)evolutionary story of enzymes and receptors
@en
Human CD38: a (r)evolutionary story of enzymes and receptors
@nl
prefLabel
Human CD38: a (r)evolutionary story of enzymes and receptors
@ast
Human CD38: a (r)evolutionary story of enzymes and receptors
@en
Human CD38: a (r)evolutionary story of enzymes and receptors
@nl
P2093
P3181
P1433
P1476
Human CD38: a (r)evolutionary story of enzymes and receptors
@en
P2093
P3181
P356
10.1016/S0145-2126(00)00093-X
P407
P577
2001-01-01T00:00:00Z